Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nurix Therapeutics (NRIX) Return on Assets (2020 - 2025)

Historic Return on Assets for Nurix Therapeutics (NRIX) over the last 6 years, with Q4 2025 value amounting to 0.44%.

  • Nurix Therapeutics' Return on Assets fell 1100.0% to 0.44% in Q4 2025 from the same period last year, while for Nov 2025 it was 0.44%, marking a year-over-year decrease of 1100.0%. This contributed to the annual value of 0.39% for FY2025, which is 100.0% down from last year.
  • Nurix Therapeutics' Return on Assets amounted to 0.44% in Q4 2025, which was down 1100.0% from 0.44% recorded in Q3 2025.
  • Over the past 5 years, Nurix Therapeutics' Return on Assets peaked at 0.14% during Q1 2021, and registered a low of 0.45% during Q1 2023.
  • Its 5-year average for Return on Assets is 0.35%, with a median of 0.39% in 2022.
  • Per our database at Business Quant, Nurix Therapeutics' Return on Assets tumbled by -2000bps in 2022 and then soared by 1100bps in 2024.
  • Over the past 5 years, Nurix Therapeutics' Return on Assets (Quarter) stood at 0.24% in 2021, then tumbled by -70bps to 0.41% in 2022, then decreased by -5bps to 0.43% in 2023, then grew by 25bps to 0.33% in 2024, then tumbled by -33bps to 0.44% in 2025.
  • Its Return on Assets was 0.44% in Q4 2025, compared to 0.44% in Q3 2025 and 0.34% in Q2 2025.